To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
The Office of Faculty Affairs and Professional Development at Wayne State University’s (WSU) School of Medicine held its 2024 School of Medicine Faculty Awards and Promotion and Tenure Ceremony on Sept. 26. This is an annual recognition of faculty who have made outstanding contributions to teaching, mentoring, research, and leadership. This year, several Barbara Ann Karmanos Cancer Institute faculty, researchers and medical staff at the Karmanos Cancer Center received these awards, highlighting their si...
The Barbara Ann Karmanos Cancer Institute and Wayne State University will host the Sixth Annual Lymphoma Symposium on Saturday, Aug. 3. This year’s symposium will feature lymphoma specialists from Memorial Sloan Kettering Cancer Center, the National Cancer Institute, Columbia University, and more, in addition to Karmanos experts. “As program director, I look forward to hosting the annual symposium each year,” said Dipenkumar Modi, M.D. , hematologist, medical oncologist, and member of the Bone Marrow an...
The ASCO Post A new four-drug therapy called Smart Stop was presented at the 2023 American Society of Hematology (ASH) Annual Meeting & Exposition. Investigators reported this targeted therapy is promising for first-line treatment of diffuse large B-cell lymphoma (DLBCL). Dipenkumar Modi, M.D. , hematologist and medical oncologist, and member of the Bone Marrow & Stem Cell Transplant and Hematology Oncology Multidisciplinary Teams at Karmanos, reviewed the study and agrees that Smart Stop could ...
ASH Abstract Achievement Award- 2017
Young Investigator Travel Grant Recipient, Society of Hematologic Oncology (SOHO) Annual Meeting- 2017
Recognition Award, Wayne State University 2016 In the area of Citizenship And Academic Achievement
Clinical Research Award, Wayne State University - 2015
Young Achiever Award, American College of Physicians National Conference- 2014